These results raise two major thoughts: first, that TDO2-associated Trp metabolism and its potential influence on liver inflammation is independent of IDO1; and second, that in the context of NAFLD/NASH, hepatic Trp levels and metabolism is more complex than we anticipated. This evidence concerns the gene IDO1 and metabolic dysfunction-associated steatohepatitis.